{"id":"procaine-penicillin-and-gentamicin","safety":{"commonSideEffects":[{"rate":"null","effect":"Nephrotoxicity"},{"rate":"null","effect":"Ototoxicity"},{"rate":"null","effect":"Hypersensitivity reactions"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Procaine penicillin is a water-soluble ester prodrug of penicillin G, which is converted to penicillin G in the body. Penicillin G then binds to penicillin-binding proteins (PBPs) located inside the bacterial cell wall, resulting in the disruption of the bacterial cell wall synthesis and ultimately leading to bacterial cell death. Gentamicin, on the other hand, is an aminoglycoside antibiotic that binds to the 30S subunit of the bacterial ribosome, thereby inhibiting protein synthesis and leading to bacterial cell death.","oneSentence":"Procaine penicillin acts as a prodrug of penicillin G, which inhibits bacterial cell wall synthesis, while gentamicin is an aminoglycoside antibiotic that inhibits protein synthesis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:30:21.366Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of bacterial infections, including pneumonia, meningitis, and septicemia"}]},"trialDetails":[{"nctId":"NCT06712641","phase":"PHASE4","title":"Aminoglycosides in Early Sepsis","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Akershus","startDate":"2026-04","conditions":"Sepsis","enrollment":1900},{"nctId":"NCT02701595","phase":"PHASE3","title":"Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Streptococcus","status":"COMPLETED","sponsor":"University Hospital, Tours","startDate":"2016-02-29","conditions":"Infective Endocarditis","enrollment":324},{"nctId":"NCT04876131","phase":"PHASE4","title":"Single Dose Intravenous Antibiotics for Complicated Urinary Tract Infections in Children","status":"RECRUITING","sponsor":"Murdoch Childrens Research Institute","startDate":"2022-05-30","conditions":"Complicated Urinary Tract Infection, Infection, Pediatric Infectious Disease","enrollment":452},{"nctId":"NCT03997266","phase":"PHASE4","title":"NICU Antibiotics and Outcomes Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Michael Morowitz","startDate":"2020-08-05","conditions":"Microbial Colonization, Extreme Prematurity, Early-Onset Neonatal Sepsis","enrollment":802},{"nctId":"NCT03915366","phase":"PHASE2, PHASE3","title":"Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe Pneumonia","status":"COMPLETED","sponsor":"Hospital Universitario 12 de Octubre","startDate":"2020-03-01","conditions":"Pneumonia, HIV/AIDS, Tuberculosis","enrollment":563},{"nctId":"NCT07107477","phase":"PHASE3","title":"TAILORED Therapeutic Regime in Patients With Preterm Premature Rupture Of Membranes to Prolong Pregnancy, Improve Maternal and Neonatal Outcomes, and Reduce Antibiotic Burden","status":"RECRUITING","sponsor":"The Central and Eastern European Gynecologic Oncology Group","startDate":"2025-05-01","conditions":"Preterm Premature Rupture of Membranes (PPROM)","enrollment":138},{"nctId":"NCT05469984","phase":"NA","title":"Comparing Two Prophylactic Antibiotic Protocols in Women With Term Prolonged Pre-labor Rupture of Membrane and Preterm Labor","status":"RECRUITING","sponsor":"Western Galilee Hospital-Nahariya","startDate":"2022-11-25","conditions":"Preterm Labor With Preterm Delivery, Premature Rupture of Membranes Prolonged","enrollment":600},{"nctId":"NCT02829060","phase":"NA","title":"Endourology Disease Group Excellence (EDGE) Consortium: Antibiotics (Abx) for Percutaneous Nephrolithotomy (PCNL) Part 2","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2016-01","conditions":"Nephrolithiasis, Urinary Tract Infection (UTI), Sepsis","enrollment":330},{"nctId":"NCT05929599","phase":"NA","title":"Efficacy of LiveSpo Navax in Supportive Treatment of Pneumonia in Children With RSV and Bacterial Co-infections","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Children's Hospital, Vietnam","startDate":"2023-07-05","conditions":"Acute Respiratory Tract Infections, Pneumonia, Respiratory Syncytial Virus (RSV)","enrollment":120},{"nctId":"NCT04041791","phase":"PHASE3","title":"A Study to Compare Different Antibiotics and Different Modes of Fluid Treatment for Children With Severe Pneumonia","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2019-08-19","conditions":"Pneumonia","enrollment":4392},{"nctId":"NCT02784821","phase":"PHASE2","title":"Antibiotic \"Dysbiosis\" in Preterm Infants","status":"COMPLETED","sponsor":"University of Florida","startDate":"2017-01-16","conditions":"Enterocolitis, Necrotizing, Bacteremia, Bronchopulmonary Dysplasia","enrollment":98},{"nctId":"NCT02865564","phase":"NA","title":"Effect of Lactobacillus Reuteri DSM17938 in Neonates Treated With Antibiotics","status":"COMPLETED","sponsor":"University Medical Centre Ljubljana","startDate":"2016-11","conditions":"Gastrointestinal Diseases, Colic","enrollment":98},{"nctId":"NCT02848820","phase":"PHASE4","title":"Initial Non-operative Treatment Strategy Versus Appendectomy Treatment Strategy for Simple Appendicitis in Children","status":"UNKNOWN","sponsor":"Ramon Gorter","startDate":"2016-12","conditions":"Appendicitis","enrollment":302},{"nctId":"NCT02579161","phase":"PHASE3","title":"Trial of Randomized Antibiotic Administration in Percutaneous Nephrolithotomy","status":"COMPLETED","sponsor":"Northwell Health","startDate":"2014-09","conditions":"Kidney Stones","enrollment":98},{"nctId":"NCT05977400","phase":"PHASE3","title":"NICU Antibiotics and Outcomes (NANO) Follow-up Study","status":"NOT_YET_RECRUITING","sponsor":"Sharp HealthCare","startDate":"2024-04","conditions":"Premature Birth, Antibiotics, Neurodevelopment","enrollment":802},{"nctId":"NCT05106803","phase":"","title":"Antibiotic Profile of Pathogenic Bacteria Isolated in Public Hospitals in Northern Jordan","status":"COMPLETED","sponsor":"Yarmouk University","startDate":"2019-08-01","conditions":"Bacterial Infections, Antibiotic Resistant Infection, Surgical Site Infection","enrollment":24},{"nctId":"NCT05051163","phase":"PHASE2, PHASE3","title":"Strategies to Reduce Mortality Among HIV-infected and HIV-exposed Children Admitted With Severe Acute Malnutrition","status":"UNKNOWN","sponsor":"Makerere University","startDate":"2021-06-14","conditions":"HIV-1-infection, Malnutrition, Child","enrollment":300},{"nctId":"NCT04132115","phase":"","title":"Optimized Antibiotic Therapy in Patients With Subarachnoid Haemorrhage (ES) and Cerebral Haemorrhage (EC)","status":"UNKNOWN","sponsor":"Azienda Sanitaria-Universitaria Integrata di Udine","startDate":"2019-10-01","conditions":"Therapeutic Drug Monitoring, Subarachnoid Hemorrhage, Intracerebral Hemorrhage","enrollment":104},{"nctId":"NCT03369093","phase":"NA","title":"RCT of Efficacy of Amoxicillin Over Ampicillin on Severe Pneumonia","status":"COMPLETED","sponsor":"International Centre for Diarrhoeal Disease Research, Bangladesh","startDate":"2018-01-01","conditions":"Treatment Failure, Lethargy, Altered Mental Status","enrollment":308},{"nctId":"NCT02099240","phase":"EARLY_PHASE1","title":"Patients Response to Early Switch To Oral:Osteomyelitis Study","status":"TERMINATED","sponsor":"Julio Ramirez","startDate":"2014-03-06","conditions":"Osteomyelitis","enrollment":11},{"nctId":"NCT02960919","phase":"","title":"Innovative Treatments in Pneumonia (ITIP) 3","status":"COMPLETED","sponsor":"Save the Children","startDate":"2016-10-19","conditions":"Pneumonia","enrollment":1001},{"nctId":"NCT02477423","phase":"NA","title":"A Randomized Controlled Trial Investigating if Antibiotic Use in the First 48 Hours of Life Adversely Impacts the Preterm Infant Microbiome","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2015-07","conditions":"Premature Birth of Newborn, Enterocolitis, Necrotizing","enrollment":27},{"nctId":"NCT03174236","phase":"PHASE3","title":"First Line Antimicrobials in Children With Complicated Severe Acute Malnutrition","status":"UNKNOWN","sponsor":"University of Oxford","startDate":"2017-09-04","conditions":"Malnutrition Severe, Antibiotic Resistance, Antibiotic Toxicity","enrollment":2000},{"nctId":"NCT02384200","phase":"PHASE4","title":"A Randomized Trial of Preoperative Prophylactic Antibiotics Prior to Kidney Stone Surgery (Percutaneous Nephrolithotomy [PCNL])","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2015-03","conditions":"Nephrolithiasis, Urinary Tract Infections","enrollment":86},{"nctId":"NCT02018094","phase":"PHASE4","title":"The Amputation Surgical Site Infection Trial (ASSIT)","status":"COMPLETED","sponsor":"Hull University Teaching Hospitals NHS Trust","startDate":"2013-10-08","conditions":"Wound Infection, Amputation Wound","enrollment":160},{"nctId":"NCT01994993","phase":"PHASE2, PHASE3","title":"Antibiotic Safety (SCAMP)","status":"COMPLETED","sponsor":"Michael Cohen-Wolkowiez","startDate":"2013-12","conditions":"Complicated Intra Abdominal Infections","enrollment":260},{"nctId":"NCT02427932","phase":"","title":"Pharmacokinetic (PK) and Pharmacodynamic (PD) Modeling of Ampicillin and Gentamicin in Peripartum Patients","status":"COMPLETED","sponsor":"Stanford University","startDate":"2015-05","conditions":"Drug Metabolism During Pregnancy","enrollment":45},{"nctId":"NCT01633294","phase":"PHASE2, PHASE3","title":"Antibiotic Prophylaxis in Prelabor Rupture of Membranes at Term","status":"COMPLETED","sponsor":"Hospital de Santa Maria, Portugal","startDate":"2008-10","conditions":"Chorioamnionitis, Puerperal Endometritis, Neonatal Early Onset Sepsis","enrollment":161},{"nctId":"NCT01027429","phase":"PHASE3","title":"Simplified Antibiotic Therapy for Sepsis in Young Infants","status":"COMPLETED","sponsor":"Aga Khan University","startDate":"2009-12","conditions":"Neonatal Sepsis, Sepsis, Infection","enrollment":2543},{"nctId":"NCT01551394","phase":"PHASE3","title":"Efficacy, Pharmacokinetics and Safety of Meropenem in Infants Below 90 Days With Clinical or Confirmed Late-onset Sepsis","status":"COMPLETED","sponsor":"PENTA Foundation","startDate":"2012-09","conditions":"Sepsis","enrollment":272},{"nctId":"NCT01333982","phase":"NA","title":"Neonatal Sepsis, Evaluation, Bangladesh","status":"COMPLETED","sponsor":"International Centre for Diarrhoeal Disease Research, Bangladesh","startDate":"2010-04","conditions":"Sepsis","enrollment":20000},{"nctId":"NCT00844337","phase":"NA","title":"Simplified Antibiotic Regimens for Outpatient Treatment of Suspected Sepsis in Neonates and Young Infants in Bangladesh","status":"COMPLETED","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2009-03","conditions":"Sepsis","enrollment":2490},{"nctId":"NCT01678365","phase":"PHASE4","title":"Safety and Efficacy of Single Daily Dose of Ceftriaxone and Metronidazole for Treatment of Complicated Appendicitis in Children","status":"COMPLETED","sponsor":"HaEmek Medical Center, Israel","startDate":"2008-07","conditions":"Complicated Appendicitis","enrollment":43},{"nctId":"NCT01559753","phase":"PHASE4","title":"Early-onset Ventilator-associated Pneumonia in Adults: Comparison of 8 Versus 15 Days of Antibiotic Treatment","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Besancon","startDate":"1998-01","conditions":"Pneumonia Ventilator Associated","enrollment":225},{"nctId":"NCT01349738","phase":"","title":"Asymptomatic Bacteriuria & Risk of Urinary Tract Infection in Renal Transplants","status":"UNKNOWN","sponsor":"Rice, James C., M.D.","startDate":"2011-05","conditions":"Bacteriuria, Urinary Tract Infections, Asymptomatic Infections","enrollment":200},{"nctId":"NCT00487019","phase":"","title":"Management of Early Onset Neonatal Septicaemia: Selection of Optimal Antibacterial Regimen for Empiric Treatment","status":"COMPLETED","sponsor":"University of Tartu","startDate":"2006-08","conditions":"Early Onset Neonatal Sepsis","enrollment":281},{"nctId":"NCT00189384","phase":"PHASE3","title":"Efficacy Study of Community-Based Treatment of Serious Bacterial Infections in Young Infants","status":"UNKNOWN","sponsor":"Aga Khan University","startDate":"2003-11","conditions":"Bacterial Infection, Sepsis, Infant, Newborn","enrollment":426}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"procaine penicillin and gentamicin","genericName":"procaine penicillin and gentamicin","companyName":"Aga Khan University","companyId":"aga-khan-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Procaine penicillin acts as a prodrug of penicillin G, which inhibits bacterial cell wall synthesis, while gentamicin is an aminoglycoside antibiotic that inhibits protein synthesis. Used for Treatment of bacterial infections, including pneumonia, meningitis, and septicemia.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}